EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Translate Bio's enterprise value is $2,214.6 Mil.
Translate Bio's Revenue for the trailing twelve months (TTM) ended in Jun. 2021 was $225.1 Mil. Therefore, Translate Bio's EV-to-Revenue for today is 9.84.
The historical rank and industry rank for Translate Bio's EV-to-Revenue or its related term are showing as below:
TBIO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.82 Med: 39.39 Max: 1463.85
Current: 9.84
During the past 5 years, the highest EV-to-Revenue of Translate Bio was 1463.85. The lowest was 3.82. And the median was 39.39.
TBIO's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 7.63
vs TBIO: 9.84
As of today (2024-04-25), Translate Bio's stock price is $37.36.
Translate Bio's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2021 was $2.90. Therefore, Translate Bio's PS Ratio for today is 12.87.
Translate Bio EV-to-Revenue Historical Data
The historical data trend for Translate Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Translate Bio's EV-to-Revenue
For the Biotechnology subindustry, Translate Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Translate Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Translate Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Translate Bio's EV-to-Revenue falls into.
Translate Bio's current Enterprise Value is $2,214.6 Mil.
Translate Bio's Revenue for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $225.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translate Bio (NAS:TBIO) EV-to-Revenue Explanation
Translate Bio's share price for today is $37.36.
Translate Bio's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.90.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translate Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Translate Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Translate Bio (Translate Bio) Business Description
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TBIO has been successfully added to your 